Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Orexo AB: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

28 Mar 2015 Reuters Investment Profile 12 $20.00

Wright Investors Service Comprehensive Report for Orexo Ab

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

13 Mar 2015 Wright Reports 56 $75.00

Orexo AB (ORX) - Financial and Strategic SWOT Analysis Review

Orexo AB (ORX) - Financial and Strategic SWOT Analysis Review Summary Orexo AB (Orexo) is an emerging specialty pharmaceutica...

10 Mar 2015 GlobalData 51 $125.00

Can Orexo AB Rebound?

17 Feb 2015 Sadif Analytics Prime 12 $25.00

OREXO - FOUNDATIONS LAID TO ACCELERATE ZUBSOLV GROWTH

Zubsolv had a strong start to 2015, approaching c 6% market share by volume of the US opioid dependence market in January, up...

10 Feb 2015 Edison Investment Research 7 $10.00

Can a Battered Orexo AB Make a Comeback?

30 Dec 2014 Sadif Analytics Prime 12 $25.00

OREXO - LOOKING BACK TO THE FUTURE

Lead product Zubsolv has captured a 4% share by volume of the US opioid dependence market a year after its launch. Orexo is c...

05 Nov 2014 Edison Investment Research 12 $10.00

Orexo AB: Upgraded to Average

03 Nov 2014 Sadif Analytics Prime 3 $10.00

Orexo AB (ORX) - Financial and Strategic SWOT Analysis Review

Orexo AB (ORX) - Financial and Strategic SWOT Analysis Review Summary Orexo AB (Orexo) is an emerging specialty pharmaceutica...

15 Oct 2014 GlobalData 50 $125.00

Is Orexo AB In Need of A Cure?

03 Oct 2014 Sadif Analytics Prime 12 $25.00